7%; p =?.033), and major vascular complications (MVASC) (6.6 vs. https://www.selleckchem.com/products/hg6-64-1.html 2.7%; p =?.050) were more frequent in HA. Pronounced calcification of the noncoronary cusp and left ventricular outflow tract, the condition of HA, as well as repositioning maneuvers were independent predictors for overall specific AE. CONCLUSION An HA above 51° is associated with an increased rate of stroke, MVASC, and 30-day mortality. Valve size and asymmetric calcification affect the incidence of repositioning maneuvers and subsequent VARC-2 AE, indicating that an HA-together with specific anatomic features-remains a crucial factor for TAVR-related outcome with self-expandable new-generation devices. © 2020 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals, Inc.BACKGROUND Microdissection testicular sperm extraction (microTESE) is considered the gold standard method of sperm retrieval from patients with non-obstructive azoospermia (NOA). For careful and thorough examination of seminiferous tubules during microTESE, maximizing surface area of the testicles which we are able to search is essential. OBJECTIVES To develop a systematic procedure for microTESE to maximize surface area and to achieve high sperm retrieval rate (SRR) in microTESE. MATERIALS AND METHODS We simulated microTESE using three-dimensional (3D) simulation model and analyzed mathematically the sum of the surface area in various methods. The best method obtained from this simulation model was applied to 102 patients with NOA from 2014 to 2018. These new clinical results were compared with those of 56 patients who underwent a previous method of microTESE from 2011 to 2014. RESULTS The mathematical 3D-simulation model of microTESE indicated that a longitudinal incision on the tunica albuginea and followi This article is protected by copyright. All rights reserved.INTRODUCTION The tracheostomy site and adjacent skin is at risk for recurrence in head/neck squamous cell cancer patients. The tracheostomy tube is an in situ device located directly over the tracheostomy site and may have clinical implications on the radiation dose delivered to the peristomal region. This study aimed to investigate this effect by comparing the prescribed treatment planning dose with the actual dose in vivo to the peristomal clinical target region. A retrospective, dosimetric study was performed with approval of the institutional research ethics board. METHODS Fifteen patients who had received high-dose radiotherapy to the tracheostomy region with in vivo dose measurements were included. The radiation dose at the skin surface underneath the tracheostomy device was measured using an optically stimulated luminescent dosimeter (OSLD) and was compared with the prescribed dose from the radiation planning system. The effect of the tracheostomy flange and/or soft tissue equivalent bolus on the periserican Association of Physicists in Medicine.Although emergency medicine is an incredibly rewarding profession, it is undeniably marked by significant levels of stress. We discuss a study by Kline et al published in Academic Emergency Medicine, April 2020, looking at dog therapy and art therapy as possible interventions to reduce emergency provider stress on shift. We provide critical analysis of the article, and summarize the social media discussion and a podcast in which the authors discuss their work. This article is protected by copyright. All rights reserved.BACKGROUND Knee arthroscopy (KA) is a routine orthopedic procedure recommended to repair cruciate ligaments and meniscus injuries and in eligible patients, to assist the diagnosis of persistent knee pain. KA is associated with a small risk of thromboembolic events. This systematic review aims to assess if pharmacological or non-pharmacological interventions may reduce this risk. This review is the second update of the review first published in 2007. OBJECTIVES To assess the efficacy and safety of interventions, whether mechanical, pharmacological, or in combination, for thromboprophylaxis in adult patients undergoing KA. SEARCH METHODS For this update, the Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register, the CENTRAL, MEDLINE, Embase and CINAHL databases, and the World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov trials registries, on 14 August 2019. SELECTION CRITERIA We included randomized controlled trials (RCTs) and adult patients undergoing KA will develop venous thromboembolism (PE or DVT). There is moderate- to low-certainty evidence of no benefit from the use of LMWH, aspirin or rivaroxaban in reducing this small risk of PE or symptomatic DVT. There is very low-certainty evidence that LMWH use may reduce the risk of asymptomatic DVT when compared to no treatment but it is uncertain how this directly relates to incidence of DVT or PE in healthy patients. No evidence of differences in adverse events (including major and minor bleeding) was seen, but data relating to this were limited due to low numbers of events in the studies reporting within the comparisons. Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd.INTRODUCTION Despite randomized controlled trials showing relatively comparable clinical outcomes with triple therapy (Triple; MTX, SSZ, HCQ) vs combination therapy with TNFi+MTX (TNF/MTX), the real-world experience comparing these strategies has not been well studied. METHODS We evaluated discontinuation and clinical effectiveness of Triple vs TNFi/MTX therapy amongst RA patients in the Corrona registry. Propensity score matching (up to 13) was used to adjust for imbalances, with stratification by biologic-naïve vs biologic-experienced status. RESULTS In biologic-naïve patients, 3926 TNF/MTX and 262 Triple patients, and 3365 TNF/MTX and 130 Triple biologic-experienced patients, were potentially eligible for analysis. Before matching, numerous factors were imbalanced, with Triple patients being older, with longer RA disease duration, lower RA disease activity, and more likely to have a history of malignancy and other comorbidities. After matching, almost all (93-98%) Triple patients could be matched to TNF/MTX patient(s), and cohort characteristics were generally well balanced.